ICU vs. NMTC, NXL, SURG, POCI, COCH, DRIO, IRIX, XAIR, CODX, and PTHL
Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include NeuroOne Medical Technologies (NMTC), Nexalin Technology (NXL), SurgePays (SURG), Precision Optics (POCI), Envoy Medical (COCH), DarioHealth (DRIO), IRIDEX (IRIX), Beyond Air (XAIR), Co-Diagnostics (CODX), and Pheton Holdings Ltd Class A Ordinary Shares (PTHL). These companies are all part of the "medical equipment" industry.
SeaStar Medical vs.
SeaStar Medical (NASDAQ:ICU) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, community ranking, institutional ownership, media sentiment and risk.
SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500.
1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 2.1% of SeaStar Medical shares are held by insiders. Comparatively, 7.5% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, SeaStar Medical had 1 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 1 mentions for SeaStar Medical and 0 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.50 beat SeaStar Medical's score of -0.55 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.
NeuroOne Medical Technologies has higher revenue and earnings than SeaStar Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
SeaStar Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -356.76%. SeaStar Medical's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.
NeuroOne Medical Technologies received 62 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 71.59% of users gave NeuroOne Medical Technologies an outperform vote.
Summary
NeuroOne Medical Technologies beats SeaStar Medical on 9 of the 14 factors compared between the two stocks.
Get SeaStar Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SeaStar Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICU) was last updated on 1/21/2025 by MarketBeat.com Staff
Free ICU Stock Alerts